What it is. Zilretta is triamcinolone — the same
steroid in an ordinary cortisone shot — loaded into tiny dissolvable
microspheres. Instead of flooding the knee and washing out into the bloodstream
within days, the microspheres release the steroid slowly, inside the joint — tiny doses over
the following months instead of one big dose on day one. It is FDA-approved specifically for osteoarthritis pain of the knee, and
it’s given as a single injection.2 Because it’s a knee-only,
knee-specific product, we’ve kept it here rather than crowding it onto our
knee page — but if your knee is the joint in
question, this section is for you.
What the research shows — plainly. In the
pivotal trial — 484 patients with knee arthritis, followed for 24 weeks —
patients who got Zilretta reported their average daily pain dropped by about three
points on a ten-point scale by week 12, roughly half of where they started, and
significantly more than the saline placebo group.3 It beat placebo on
every secondary measure too, including cumulative pain relief through week
24.3 Side effects were mild and no more common than with the other
injections in the trial.3
Now the part a sales brochure would skip. The trial
also compared Zilretta head-to-head with an ordinary cortisone shot. On the main
pain measure at 12 weeks, the difference between the two was not statistically
significant.3 On several other measures — function, and quality of
life — Zilretta came out ahead,3 but the primary comparison
didn’t clear the bar, and we won’t pretend it did. That’s also the
reason a few insurance plans still balk at covering it.
What we see. In our experience, Zilretta is simply the
better steroid option for an arthritic knee — for nearly every patient, not just
a few. Because it doses the joint slowly rather than all at once, the relief we see
typically runs three to six months instead of a couple of weeks. That’s clinical
experience, not a trial result, and we’re telling you which is which. If
you’ve had a cortisone shot that helped and then quit on you, this is the version
worth asking about.
If you have diabetes, this matters more. Ordinary
steroid injections push blood sugar up for a few days — enough that many
diabetic patients have been told to avoid them. In a small randomized study of 33
patients with type 2 diabetes and knee arthritis, average blood sugar over the three
days after injection rose about 15 mg/dL with Zilretta versus about 34 mg/dL with a
standard cortisone shot.4 That is
the whole point of the slow-release design — keep the steroid in the joint and out
of the bloodstream — and it’s why, for our diabetic patients, Zilretta is
the steroid we recommend for the knee.
Can it be repeated? The FDA label says the safety and
effectiveness of repeat injections haven’t been formally demonstrated.2
A follow-on study of 208 patients who received a second Zilretta injection 12 to 24
weeks after the first found the second worked about as well as the first, with no sign
of harm to the joint on X-rays a year later.5 In practice
it can be repeated as often as every three to four months, but we prefer to be
conservative — about once every six months — and the right interval depends
entirely on you and your knee.
Where it fits. Zilretta calms inflammation for longer.
It doesn’t replace the fluid an arthritic knee has lost — that’s the
job of gel injections, which some patients receive
alongside it at different times. And when injections of any kind stop doing the job,
genicular artery embolization treats the
inflamed lining of the knee itself, and doesn’t depend on how much cartilage is
left. Injections close no doors here.
Zilretta is covered by most insurance plans. A few plans don’t
cover it, and some ask for prior authorization first, which we handle for you. Our
complimentary benefits check tells you exactly where you stand before anything is
scheduled.